This is read by an automated voice. Please report any issues or inconsistencies here. A divided D.C. Circuit panel has cleared the Trump administration to resume fast-track deportations of ...

A federal appeals court on Tuesday allowed the Trump administration to resume carrying out speedy deportations of undocumented migrants throughout the United States, not just near the border. A ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - A massive 826,780-square-foot warehouse sits illuminated Feb. 12, 2026, in the El Paso suburb of Socorro, Texas, that was ...

Federal Appeals Court Allows the Trump Administration to Resume Expanded Use of Speedy Deportations A federal appeals court on Tuesday allowed the Trump administration to resume carrying out speedy ...

D-Cycloserine (DCS) has been reported to augment the effect of Transcranial Magnetic Stimulation (TMS) in remission from depression and suicidality in several published clinical studies. NRx ...

Android 17 is making its way to Tensor-powered Pixels, and Google has packed in plenty of new features. While app bubbles and Gemini enhancements are great, the company added some not-so-flashy ...

The IRS’s outside technology advisory panel called on Congress to provide stable, multiyear funding; expand the use of artificial intelligence; and simplify tax administration. It also warned that ...

LANSING — Expanded permitted use of golf carts on Michigan neighborhood streets appears likely, as both chambers of the Legislature have passed similar bills with strong bipartisan support. The ...

ImmunityBio receives good news all around – the U.S. Food and Drug Administration has accepted for review the company’s application for expanded use of Anktiva and it acquired a strain of a related ...

A Chinese-speaking cybercrime group has expanded its targeting to the European space, deploying previously undocumented malware and the Atlas backdoor. Tracked as TA4922, the threat actor is ...

Johnson & Johnson (JNJ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in patients with advanced head and neck ...